Visual acuity is reduced in alpha 7 nicotinic receptor knockout mice.

Authors:
Address: Neuroscience Institute (National Council of Research [CNR]), Pisa, Italy.
Journal:


Publication:

abstract

PURPOSE:

nicotinic receptors (nAChRs) are part of a heterogeneous family of pentameric ligand-gated ion channels that are widely expressed in the Visual system. The impact of α7 homomeric nAChRs on visual function was investigated using mutant mice lacking the α7 nicotinic receptor subunit.

METHODS:

The spatial resolution limit was measured in α7 knockout (α7 KO) and age-matched control mice using three independent methods: an operant behavioral visual task (Prusky maze), cortical visual evoked potentials (VEPs), and the pattern electroretinogram (PERG) evoked by alternating gratings of different spatial frequencies and contrasts.

RESULTS:

Visual acuity measured by means of the visual water maze task was significantly decreased in the α7 KO mice and, concordantly, there was a reduction of the cortical spatial resolution limit measured by VEPs. However, the PERG was normal in α7 KO mice, compared with control mice. The use of fluorescently tagged cholera toxin showed that projections from the retina segregate normally in α7 KO mice and, in line with this, the visual cortical responses elicited by stimulating either eye were normally balanced in both visual cortices and showed no retinotopic anomalies.

CONCLUSIONS:

These findings indicate that the absence of the α7 nicotinic subunit reduces visual acuity. Because the cortical output has an abnormal spatial resolution but retinal output is preserved, it can be concluded that the low visual acuity was due to a deficit specifically present in the visual cortex.



Related Articles
Requirement of the nicotinic acetylcholine receptor beta 2 subunit for the anatomical and functional development of the visual system.
Proc Natl Acad Sci U S A. 2001
Requirement of the nicotinic acetylcholine receptor beta 2 subunit for the anatomical and functional development of the visual system.
Rossi FM, Pizzorusso T, Porciatti V, Marubio LM, Maffei L, Changeux JP. Proc Natl Acad Sci U S A. 2001 May 22; 98(11):6453-8. Epub 2001 May 8.
Direction-specific disruption of subcortical visual behavior and receptive fields in mice lacking the beta2 subunit of nicotinic acetylcholine receptor.
J Neurosci. 2009
Direction-specific disruption of subcortical visual behavior and receptive fields in mice lacking the beta2 subunit of nicotinic acetylcholine receptor.
Wang L, Rangarajan KV, Lawhn-Heath CA, Sarnaik R, Wang BS, Liu X, Cang J. J Neurosci. 2009 Oct 14; 29(41):12909-18.
alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation.
Neuroscience. 2007
alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation.
Ren K, Thinschmidt J, Liu J, Ai L, Papke RL, King MA, Hughes JA, Meyer EM. Neuroscience. 2007 Mar 2; 145(1):314-22. Epub 2007 Jan 9.
Review Development of retinal and cortical responses to pattern reversal in infants: a selective review.
Behav Brain Res. 1983
Review Development of retinal and cortical responses to pattern reversal in infants: a selective review.
Fiorentini A, Pirchio M, Spinelli D. Behav Brain Res. 1983 Oct; 10(1):99-106.
Review The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).
Behav Brain Res. 2000
Review The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).
Kem WR. Behav Brain Res. 2000 Aug; 113(1-2):169-81.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.